Lacey Matheis
Family · Evansville, INNPI 1205235165
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $93,326 of the $139,336 with a category attached, or 67.0%. Acadia Pharmaceuticals Inc accounts for 69.9% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $44,284, 3.3 times the $13,281 reported in 2021. Among family clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 317 payments — averaging $439.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$97K
- Mylan Specialty L.p.$24K
- Viatris Specialty LLC$18K
- Urovant Sciences Inc$188
- Biohaven Pharmaceuticals, Inc.$124
What the payments were for
- Consulting fees$3,2732%
- Speaking & faculty fees$93,32667%
- Travel & lodging$35,66626%
- Food & beverage$7,0615%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 236 | $97,355 |
| Mylan Specialty L.p. | 44 | $23,908 |
| Viatris Specialty LLC | 28 | $17,760 |
| Urovant Sciences Inc | 8 | $188 |
| Biohaven Pharmaceuticals, Inc. | 1 | $124 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUPLAZID$94,420
- Yupelri$40,947
- GEMTESA$125
- NURTEC ODT$124
How this compares
$139,336 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 11 | $11,318 |
| EliquisApixaban | 37 | $9,046 |
| GemtesaVibegron | 17 | $4,185 |
| MyrbetriqMirabegron | 13 | $2,988 |
| Scopolamine | 17 | $2,252 |
| Memantine Hcl | 57 | $2,162 |
| Fluvoxamine Maleate ErFluvoxamine Maleate | 14 | $2,077 |
| Fluconazole | 31 | $1,344 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $1,183 |
| Midodrine Hcl | 13 | $837 |
| Potassium Chloride | 24 | $554 |
| Metoprolol Succinate | 25 | $372 |
| Mirtazapine | 17 | $321 |
| Buspirone Hcl | 17 | $320 |
| Citalopram HbrCitalopram Hydrobromide | 20 | $318 |
Paid to pharmacies, not to this prescriber.
Other family in Evansville
- Kathalene Keller RineyEvansville$383K
- Elizabeth JohnsonEvansville$108K
- Erica ThomasonEvansville$14K
- Tina SizemoreIndianapolis$888K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Myra SikwataHobart$131K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.